Edward Richard Prostko, MD | |
380 W Chestnut St Ste 101, Washington, PA 15301-4658 | |
(724) 228-1414 | |
(724) 228-8579 |
Full Name | Edward Richard Prostko |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 380 W Chestnut St Ste 101, Washington, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336134840 | NPI | - | NPPES |
10934442 | Other | CAQH | |
000888021 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | MD024694E (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Edward Richard Prostko, MD 380 W Chestnut St Ste 101, Washington, PA 15301-4658 Ph: (724) 228-1414 | Edward Richard Prostko, MD 380 W Chestnut St Ste 101, Washington, PA 15301-4658 Ph: (724) 228-1414 |
News Archive
Many studies favor an extended lymphadenectomy at the time of a potentially curative gastrectomy for node-positive gastric cancer, and the risk of long-term death tends to decrease when the number of resected lymph nodes increases to about 25. However, few studies have assessed the relative contribution of the total number of resected lymph nodes to the outcome of patients with node-negative gastric cancer.
A new risk calculator can predict the risk of postoperative complications occurring for individual bariatric surgery patients, according to a study published in the March issue of the Journal of the American College of Surgeons. The risk calculator will help in surgical decision-making and will help patients better understand what they can expect during recovery in order to prepare for a bariatric operation.
A team of researchers from various institutions within the Netherlands examined the use of targeted MS-based proteomics for the detection of SARS-CoV-2 in research and clinical samples.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today enrollment of the first patient in a Phase 1/2 trial of BL-7010, for the treatment of celiac disease. The first patient was enrolled at Tampere Hospital in Finland, a world-leading site for celiac disease research. Results are expected in mid-2014.
A new survey says a significant number of women being treated for infertility would choose the sex of their next child if given the option - and those as yet childless would choose baby girls and boys in approximately equal numbers.
› Verified 3 days ago
Donald M Whiting, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 380 W Chestnut St Ste 101, Washington, PA 15301 Phone: 724-228-1414 Fax: 724-228-8579 | |
Nestor D Tomycz, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 380 W Chestnut St Ste 101, Washington, PA 15301 Phone: 724-228-1414 Fax: 724-228-8579 | |
Dr. Frank T Vertosick, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 380 W Chestnut St, Suite 101, Washington, PA 15301 Phone: 724-228-1414 Fax: 724-228-8579 |